3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Conditions
Leiomyoma
6
Myofibroma
1
Metrorrhagia
1
Menorrhagia
1
Interventions
estradiol, norethindrone drug combination
9
elagolix
7
Estradiol
7
asoprisnil
6
relugolix
5
Norethindrone Acetate
5
vilaprisan
4
Uterine Myomectomy
4
Uterine Artery Embolization
4
linzagolix
2
ulipristal acetate
1
ulipristal
1
pycnogenols
1
Tranexamic Acid
1
Radiofrequency Ablation
1
Progesterone
1
Megestrol Acetate
1
Medroxyprogesterone Acetate
1
Ibuprofen
1
Hysterectomy
1
Endomet
1
Electrocoagulation
1
Cryosurgery
1
Acetaminophen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Menorrhagia
×
ulipristal
×
Clear all
NCT02465814
2016-11-22
ASTEROID 2
Bayer
Phase 2
Completed
120 enrolled